(ETON) Eton Pharmaceuticals - Performance 323% in 12m
ETON performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
46.89%
#17 in Peer-Group
Rel. Strength
98.90%
#85 in Stock-Universe
Total Return 12m
322.99%
#5 in Peer-Group
Total Return 5y
143.89%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 47.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 20.25 USD |
| 52 Week Low | 3.26 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 3.83 |
| Buy/Sell Signal +-5 | -0.50 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ETON (323%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-5.57% | 148% | 352% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
6.63% | -8.12% | 432% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
7.57% | 3.97% | 55.4% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
6.89% | -5.39% | 56.7% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: ETON vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ETON
| Total Return (including Dividends) | ETON | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -25.15% | 4.35% | 1.43% |
| 3 Months | -7.33% | -6.89% | 6.58% |
| 12 Months | 322.99% | -5.08% | 11.56% |
| 5 Years | 143.89% | 50.53% | 107.90% |
| Trend Score (consistency of price movement) | ETON | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -90.9% | 65.8% | 74.5% |
| 3 Months | 65.2% | -68.7% | 72.6% |
| 12 Months | 92.6% | -63.3% | 43.3% |
| 5 Years | -1.8% | 88.4% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #189 | -26.59% | -26.20% |
| 3 Month | #115 | -0.16% | -13.05% |
| 12 Month | #3 | 347.00% | 279.15% |
| 5 Years | #10 | 65.79% | 17.31% |
FAQs
Does Eton Pharmaceuticals (ETON) outperform the market?
Yes,
over the last 12 months ETON made 322.99%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months ETON made -7.33%, while XLV made -6.89%.
Performance Comparison ETON vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ETON vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.1% | -26.6% | 11.3% | 311% |
| US NASDAQ 100 | QQQ | -9.9% | -26.6% | 13% | 314% |
| German DAX 40 | DAX | -7.9% | -24.4% | -4.1% | 294% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.3% | -24.7% | 10% | 311% |
| Hongkong Hang Seng | HSI | -9.9% | -29.2% | -6% | 296% |
| India NIFTY 50 | INDA | -9.4% | -25% | 12.3% | 324% |
| Brasil Bovespa | EWZ | -13.1% | -26.3% | -8.7% | 313% |
ETON vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.8% | -26.6% | 9.4% | 300% |
| Consumer Discretionary | XLY | -9.6% | -23.4% | 22.1% | 305% |
| Consumer Staples | XLP | -9.8% | -24.9% | 10.7% | 316% |
| Energy | XLE | -16% | -28.1% | 8.6% | 320% |
| Financial | XLF | -8.6% | -22.6% | 9.4% | 299% |
| Health Care | XLV | -12.1% | -29.5% | 12.7% | 328% |
| Industrial | XLI | -9.1% | -25.5% | 6.7% | 305% |
| Materials | XLB | -9.5% | -26.6% | 11.4% | 324% |
| Real Estate | XLRE | -10.7% | -26.1% | 11.2% | 310% |
| Technology | XLK | -10.5% | -27.2% | 11.8% | 319% |
| Utilities | XLU | -11.5% | -25.7% | 3.9% | 302% |
| Aerospace & Defense | XAR | -9.2% | -30.9% | -4.7% | 280% |
| Biotech | XBI | -9.8% | -32.9% | 23% | 331% |
| Homebuilder | XHB | -8.5% | -20.1% | 27.6% | 332% |
| Retail | XRT | -6.2% | -25% | 20.2% | 322% |
ETON vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -21.9% | -43.8% | 2.37% | 320% |
| Natural Gas | UNG | -9.4% | -22.5% | -6.1% | 338% |
| Gold | GLD | -12.3% | -31.1% | -16.1% | 278% |
| Silver | SLV | -9.3% | -36.5% | -7.4% | 301% |
| Copper | CPER | -9% | -30.7% | -4.3% | 313% |
ETON vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -11.6% | -25.8% | 13.7% | 327% |
| iShares High Yield Corp. Bond | HYG | -10.8% | -25.8% | 8.3% | 314% |